Viking Therapeutics Newsroom

Positive Phase 2 Trial Results Drive Viking Therapeutics (VKTX) Stock Upwards

TipRanks18:16

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?

Yahoo FinanceNov 23 00:31

How Is The Market Feeling About Viking Therapeutics?

BenzingaNov 23 00:15

Viking Therapeutics Analyst Ratings

BenzingaNov 22 21:24 · Ratings

B.Riley Financial Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $109

Futu NewsNov 22 09:32 · Ratings

Viking Therapeutics: Strong Potential in Obesity and Type 2 Diabetes Market With Innovative VK2735 Program

TipRanksNov 22 09:15

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs

Analyst UpgradesNov 21 02:26

Viking Therapeutics Is Winning New Fans - and Not for Its Weigh-loss Pill

MarketWatchNov 21 01:30

Express News | Viking Therapeutics Shares Rise 4.6% Premarket After Co Presents Detailed Mid-Stage Data for Experimental Liver Disease Drug

BreakingsNov 20 18:06

Viking Phase 2b Study of NASH Candidate Hits Primary Endpoint

Seeking AlphaNov 20 05:42

Express News | Viking Therapeutics Presents Results From Phase 2B Voyage Study of Vk2809 in Biopsy-Confirmed Nash/Mash at the 75TH Liver Meeting® 2024

BreakingsNov 20 05:03

Viking Therapeutics Presents Results From Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024

PR NewswireNov 20 05:03

We're Interested To See How Viking Therapeutics (NASDAQ:VKTX) Uses Its Cash Hoard To Grow

Simply Wall StNov 18 21:15

3 Things You Need to Know If You Buy Viking Therapeutics Today

Yahoo FinanceNov 18 17:45

Is It Too Late to Buy Viking Therapeutics Stock?

Yahoo FinanceNov 17 20:05

The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.

Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.

wallstreetcnNov 17 20:00

Shares of Pharmaceutical and Healthcare Stocks Are Trading Lower. The Sector Has Been Under Pressure After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS.

BenzingaNov 16 04:21

Market Whales and Their Recent Bets on VKTX Options

BenzingaNov 16 01:01

Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Raises Target Price to $164

Futu NewsNov 14 21:31 · Ratings

Oppenheimer Sticks to Their Buy Rating for Viking Therapeutics (VKTX)

TipRanksNov 14 20:58 · Ratings